Skip to content

Enovis Corp

US · ENOV #3237 by market cap
17.69 +0.26 +1.49%
Live - 5344 symbols - heartbeat 94s ago · 2026-10-09 19:30

About Enovis Corp

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Founded
1995
CEO
Mr. Damien McDonald
Employees
7,802
Headquarters
Wilmington, Delaware, United States of America
Fiscal year end
12-31
Website
enovis.com

Company profile

Exchange
US
Symbol
ENOV
Market-cap rank
#3237
Market cap
1.02B
Float cap
933.37M
Shares out
57.67M
Float shares
52.76M

Sectors & themes

Medical Devices Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-09 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Enovis Corp discussion 0 comments

Add a comment